[Influence of prolonged intraportal infusion of medicinal substances on the course of experimental acute toxic dystrophy of the liver].
D000418:Albumins / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D002252:Carbon Tetrachloride Poisoning / Q000188:drug therapy*; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy*; D004285:Dogs; D005069:Evaluation Studies as Topic; D005947:Glucose / Q000008:administration & dosage / Q000627:therapeutic use*; D007263:Infusions, Parenteral; D011168:Portal System; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D011492:Protein Hydrolysates / Q000008:administration & dosage / Q000627:therapeutic use*; D013162:Splenic Vein; D014815:Vitamins / Q000008:administration & dosage / Q000627:therapeutic use*
D000418:Albumins; D011492:Protein Hydrolysates; D014815:Vitamins; D011239:Prednisolone; D005947:Glucose
Vliianie dlitel'noĭ vnutriportal'noĭ infuzii lekarstvennykh veshchestv na techenie éksperimental'noĭ ostroĭ toksicheskoĭ distrofii pecheni